Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by Smitty2000on Dec 11, 2017 3:13pm
161 Views
Post# 27132621

RE:Foundation is set

RE:Foundation is seti agree on the fda approval. it sure took awhile, but congratulations to the mgmt team.
i thought we would see a lot more upside on the sp. lets see what happens in q1

elgin1 wrote: Ind approval for trials by FDA lays the foundation for the company. We are not done with catalysts . This is just the beginning. You cannot control the share price but the market will fairly price the catalysts . IND is revolutionary . Nothing happens over night. As trial starts and results come in, and catalysts are achieved including collaborations with pharma, future is bright .  I think this will eventually be listed on US exchange . 

For or those that trade it and are sceptical, you have every right to sell, but management does deserve some recognition for getting FDA IND approval . 

Happy holidays.


Bullboard Posts